AXGN |
Axogen, Inc. |
Sep 1, 2024 |
2 |
$0 |
4 |
Sep 4, 2024 |
Director |
VSTM |
Verastem, Inc. |
Jun 18, 2024 |
2 |
$0 |
4 |
Jun 20, 2024 |
Director |
AXGN |
Axogen, Inc. |
Jun 6, 2024 |
2 |
$0 |
4 |
Jun 10, 2024 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 5, 2024 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Mar 18, 2024 |
2 |
$429K |
4 |
Mar 18, 2024 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Mar 15, 2024 |
1 |
$0 |
4 |
Apr 1, 2024 |
Director |
VSTM |
Verastem, Inc. |
Mar 11, 2024 |
5 |
$0 |
4 |
Mar 13, 2024 |
Director |
AXGN |
Axogen, Inc. |
Sep 1, 2023 |
2 |
$0 |
4 |
Sep 7, 2023 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Jun 7, 2023 |
1 |
$0 |
4 |
Jun 7, 2023 |
Director |
AXGN |
Axogen, Inc. |
Jun 1, 2023 |
2 |
$0 |
4 |
Jun 5, 2023 |
Director |
VSTM |
Verastem, Inc. |
May 15, 2023 |
1 |
$0 |
4 |
May 16, 2023 |
Director |
VSTM |
Verastem, Inc. |
Jun 22, 2022 |
1 |
$0 |
4 |
Jun 24, 2022 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Jun 8, 2022 |
2 |
$0 |
4 |
Jun 9, 2022 |
Director |
AXGN |
Axogen, Inc. |
Jun 1, 2022 |
2 |
$0 |
4 |
Jun 3, 2022 |
Director |
VSTM |
Verastem, Inc. |
May 12, 2022 |
1 |
$0 |
4/A |
Dec 20, 2022 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Oct 5, 2021 |
8 |
$46.6K |
4/A |
Oct 8, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
Oct 5, 2021 |
2 |
$0 |
4 |
Oct 6, 2021 |
Chief Executive Officer, Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Oct 5, 2021 |
0 |
$0 |
3 |
Oct 5, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
Oct 1, 2021 |
1 |
-$690K |
4 |
Oct 5, 2021 |
Chief Executive Officer, Director |
AXGN |
Axogen, Inc. |
Jul 19, 2021 |
1 |
$0 |
4 |
Jul 21, 2021 |
Director |
AXGN |
Axogen, Inc. |
Jul 19, 2021 |
0 |
$0 |
3 |
Jul 21, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
Jul 2, 2021 |
1 |
-$157K |
4 |
Jul 7, 2021 |
Chief Executive Officer, Director |
VSTM |
Verastem, Inc. |
Jun 28, 2021 |
1 |
$0 |
4 |
Jun 30, 2021 |
Director |